Mirati Therapeutics, Inc.

UBS Group AG

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/9/2024

Shares

51,945

Value ($000)

3,052

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/9/2024	3,052	0.0%	51,945	12/31/2023
2023 Q3	11/9/2023	1,441	0.0%	33,082	9/30/2023
2023 Q2	8/11/2023	4,508	0.0%	124,768	6/30/2023
2023 Q1	5/12/2023	3,028	0.0%	81,432	3/31/2023
2022 Q4	2/8/2023	6,331	0.0%	139,732	12/31/2022
2022 Q3	11/10/2022	1,497	0.0%	21,446	9/30/2022
2022 Q2	8/10/2022	3,340	0.0%	49,762	6/30/2022
2022 Q1	5/16/2022	660	0.0%	8,031	3/31/2022
2021 Q4	2/14/2022	5,815	0.0%	39,638	12/31/2021
2021 Q3	11/15/2021	5,113	0.0%	28,906	9/30/2021
2021 Q2	8/13/2021	823	0.0%	5,096	6/30/2021
2021 Q1	5/12/2021	1,718	0.0%	10,032	3/31/2021
2020 Q4	2/11/2021	3,138	0.0%	14,290	12/31/2020
2020 Q3	11/12/2020	2,087	0.0%	12,565	9/30/2020
2020 Q2	7/31/2020	2,822	0.0%	24,713	6/30/2020
2020 Q1	5/1/2020	1,211	0.0%	15,754	3/31/2020
2019 Q4	2/14/2020	2,317	0.0%	17,980	12/31/2019